Ordenar

Buscar

01/09/2025 SOCIAL DETERMINANTS OF ALLOSTATIC LOAD DURING CHILDHOOD FROM 6 TO 12 YEARS IN 6 EUROPEAN POPULATION COHORTS
Moreno-Ferrer, S, Kusters, M, López, MJ, Thomson, E, Guxens, M. SOCIAL DETERMINANTS OF ALLOSTATIC LOAD DURING CHILDHOOD FROM 6 TO 12 YEARS IN 6 EUROPEAN POPULATION COHORTS. Gaceta Sanitaria. 2025; 39DOI:. PMID:. IF:1.500(Q3/7D).
01/09/2025 INTERVENTIONS TO MITIGATE THE EFFECTS OF RESIDENTIAL INSECURITY ON CHILDREN'S HEALTH
Pérez, AC, Balcells, JC, Pérez, AF, Thió, CB, Cano, GS, Ledesma, ES, Munne, IM, Vásquez-Vera, H, González, KP. INTERVENTIONS TO MITIGATE THE EFFECTS OF RESIDENTIAL INSECURITY ON CHILDREN'S HEALTH. Gaceta Sanitaria. 2025; 39DOI:. PMID:. IF:1.500(Q3/7D).
01/09/2025 HOUSEHOLD MPOX CASES IN 2022 IN THE SPANISH STATE: DOES THE SIZE OF THE MUNICIPALITY MATTER?
Forcadell-Díez, L, Escalé, CP, March-Yagüe, A, Domínguez, A, Toledo, D, Ospina, J, Palma, D, Rius, C. HOUSEHOLD MPOX CASES IN 2022 IN THE SPANISH STATE: DOES THE SIZE OF THE MUNICIPALITY MATTER?. Gaceta Sanitaria. 2025; 39DOI:. PMID:. IF:1.500(Q3/7D).
01/09/2025 FAMILY OUTBREAK OF MPOX IN BARCELONA: A REMINDER OF ENDEMIC PERSISTENCE AND CLINICAL VARIABILITY
Pericas, C, Martín-Ezquerra, G, Domingo, C, Masdeu, E, Marcos, I, Hernández, A, Ros, M, Simón, P, Rius, C. FAMILY OUTBREAK OF MPOX IN BARCELONA: A REMINDER OF ENDEMIC PERSISTENCE AND CLINICAL VARIABILITY. Gaceta Sanitaria. 2025; 39DOI:. PMID:. IF:1.500(Q3/7D).
01/09/2025 DESCRIPTION OF SEXUAL AND REPRODUCTIVE HEALTH IN A POPULATION IN A SITUATION OF HIGH SOCIAL VULNERABILITY
Valmayor, S, Roel, E, Gil, S, Gabaró, S, Salobral, R. DESCRIPTION OF SEXUAL AND REPRODUCTIVE HEALTH IN A POPULATION IN A SITUATION OF HIGH SOCIAL VULNERABILITY. Gaceta Sanitaria. 2025; 39DOI:. PMID:. IF:1.500(Q3/7D).
01/09/2025 EIRA, HEALTH PROTECTION INFORMATION SYSTEM
Marín, PG, Balaguero, NB, Baró, MAB, Gutiérrez, AG, Tudela, SP, Ramon, MR, Macía, VT, Muñoz, NV. EIRA, HEALTH PROTECTION INFORMATION SYSTEM. Gaceta Sanitaria. 2025; 39DOI:. PMID:. IF:1.500(Q3/7D).
01/09/2025 HEAT-RELATED MORTALITY SURVEILLANCE IN THE CITY OF BARCELONA
Oliveras, L, Marí-Dell'Olmo, M, Quijal-Zamorano, M, Gómez-Gutiérrez, A. HEAT-RELATED MORTALITY SURVEILLANCE IN THE CITY OF BARCELONA. Gaceta Sanitaria. 2025; 39DOI:. PMID:. IF:1.500(Q3/7D).
01/09/2025 EVALUATION OF THE SEXUAL AND REPRODUCTIVE HEALTH PROGRAM, SIRIAN, WITH A POPULATION IN A SITUATION OF HIGH SOCIAL VULNERABILITY
Valmayor, S, Roel, E, Gabarró, S, Gil, S, Salobral, R. EVALUATION OF THE SEXUAL AND REPRODUCTIVE HEALTH PROGRAM, SIRIAN, WITH A POPULATION IN A SITUATION OF HIGH SOCIAL VULNERABILITY. Gaceta Sanitaria. 2025; 39DOI:. PMID:. IF:1.500(Q3/7D).
01/09/2025 Azathioprine for the Treatment of Chronic Spontaneous Urticaria Refractory to Antihistamines, Omalizumab, and Ciclosporin: A Case Series
Mateu-Arrom, L, Martin, R, Expósito-Serrano, V, Alvarez-Abella, A, Serra-Baldrich, E, Spertino, J. Azathioprine for the Treatment of Chronic Spontaneous Urticaria Refractory to Antihistamines, Omalizumab, and Ciclosporin: A Case Series. Actas Dermo-Sifiliograficas. 2025; 116(8)DOI:10.1016/j.ad.2025.05.022. PMID:40480489. IF:(Q/D).
01/09/2025 Similarity of efficacy of SB17 to reference ustekinumab for moderate-to-severe psoriasis through 12 weeks in different demographic and comorbidity subgroups
Feldman, SR, Sanz, LP, Girolomoni, G, Jo, SJ, Jung, H, Jung, J. Similarity of efficacy of SB17 to reference ustekinumab for moderate-to-severe psoriasis through 12 weeks in different demographic and comorbidity subgroups. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2025; 93(3)DOI:. PMID:. IF:11.800(Q1/1D).
01/09/2025 Bimekizumab achievement of 'super response' using a previously published definition in moderate to severe plaque psoriasis: Results from four phase 3/3b trials
Lebwohl, M, Langley, RG, Strober, B, Thaçi, D, Armstrong, A, Gordon, KB, Puig, L, Davies, O, Peterson, L, Davis, L, Warren, RB. Bimekizumab achievement of 'super response' using a previously published definition in moderate to severe plaque psoriasis: Results from four phase 3/3b trials. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2025; 93(3)DOI:. PMID:. IF:11.800(Q1/1D).
01/09/2025 Towards Defining Follow-up Strategies for Patients with Primary Intermediate-risk Non-muscle-invasive Bladder Cancer
Contieri, R, Martini, A, Beijert, IJ, Mertens, LS, Hentschel, AE, Brundl, J, Compérat, EM, Plass, K, Rodríguez, O, Henríquez, JDS, Hernández, V, de la Pena, E, Alemany, I, Turturica, D, Pisano, F, Soria, F, Capoun, O, Bauerova, L, Pesl, M, Bruins, HM, Runneboom, W, Herdegen, S, Breyer, J, Brisuda, A, Calatrava, A, Rubio-Briones, J, Seles, M, Mannweiler, S, Bosschieter, J, Kusuma, VRM, Ashabere, D, Huebner, N, Seisen, T, Claps, F, Masson-Lecomte, A, Liedberg, F, Cohen, D, Lunelli, L, Cussenot, O, El Sheikh, S, Volanis, D, Cote, JF, Roupret, M, Haitel, A, Shariat, SF, Mostafid, AH, Nieuwenhuijzen, JA, Zigeuner, R, Dominguez-Escrig, JL, Hacek, J, Zlotta, AR, Burger, M, Evert, M, van de Kaa, CA, van der Heijden, AG, Kiemeney, LALM, Soukup, V, Molinaro, L, Hurle, R, Paciotti, M, Moschini, M, Pradere, B, Perdona, S, Gontero, P, Llorente, C, Algaba, F, Palou, J, N'Dow, J, Ribal, MJ, van der Kwast, TH, Babjuk, M, Sylvester, RJ, van Rhijn, BWG. Towards Defining Follow-up Strategies for Patients with Primary Intermediate-risk Non-muscle-invasive Bladder Cancer. European Urology Oncology. 2025; 8(4)DOI:10.1016/j.euo.2025.04.010. PMID:40399193. IF:9.300(Q1/1D).
01/09/2025 Clinical features of children with MOG-IgG who fulfill criteria of multiple sclerosis and overlapping disorders
Perez, EGF, Olivé, G, Chen, LW, Paredes-Carmona, F, Nuñez-Enamorado, N, Duran, SB, Mendibe, MD, Visa-Reñe, N, Vasquez-Lopez, M, Felipe-Rucián, A, Romeu, G, Martinez, E, Blanco, Y, Sepulveda, M, Saiz, A, Dalmau, J, Armangue, T. Clinical features of children with MOG-IgG who fulfill criteria of multiple sclerosis and overlapping disorders. Multiple Sclerosis Journal. 2025; 31(3)DOI:. PMID:. IF:5.000(Q1/2D).
01/09/2025 Edge-to-edge tricuspid valve repair and heart failure hospitalizations: the TRI-SPA registry
Echarte-Morales, J, Sanchis, L, Arzamendi, D, Moñivas, V, Carrasco-Chinchilla, F, Pan, MN, Nombela-Franco, L, Pascual, I, Benito-González, T, Pérez, R, Gomez-Blázquez, I, Amat-Santos, IJ, Cruz-González, I, Sánchez-Recalde, A, Alvarez, ABC, Barreiro-Pérez, M, Cepas-Guillén, P, Li, CH, del Trigo, M, Martinez-Carmona, JD, Mesa, D, Mahia, P, Avanzas, P, González-Garcia, A, Freixa, X, Estévez-Loureiro, R. Edge-to-edge tricuspid valve repair and heart failure hospitalizations: the TRI-SPA registry. REVISTA ESPANOLA DE CARDIOLOGIA. 2025; 78(9)DOI:10.1016/j.rec.2025.02.015. PMID:40154922. IF:4.900(Q1/2D).
01/09/2025 Hypochloremia in chronic and acute heart failure scenarios: Prevalence and risk factors
Llàcer, P, Marcos, MC, Croset, F, Zegri-Reiriz, I, de la Espriella, R, Ordás, JG, Forti, A, Rubio-Graciaj, J, Blazquez-Bermejo, Z, Mendez, A, Rodriguez, A, Caravaca-Perez, P, Comin-Colet, J, Morales-Rull, JL, Manzano, L, Núñez, J. Hypochloremia in chronic and acute heart failure scenarios: Prevalence and risk factors. European Journal of Internal Medicine. 2025; 139DOI:10.1016/j.ejim.2025.05.022. PMID:40500604. IF:6.100(Q1/1D).
01/09/2025 Optimising trial design for cardiogenic shock: insights from the sixth Critical Care Clinical Trialists Workshop
Kimmoun, A, O'Brien, C, Blumer, V, Wenzl, FA, Pöss, J, Zeymer, U, Moller, JE, Aissaoui, N, Sinha, SS, Combes, A, Sato, N, Sionis, A, Soussi, S, Price, S, Monroe, RE, Mathew, R, Mebazaa, A. Optimising trial design for cardiogenic shock: insights from the sixth Critical Care Clinical Trialists Workshop. Lancet Respiratory Medicine. 2025; 13(9)DOI:10.1016/S2213-2600(25)00084-0. PMID:40339587. IF:32.800(Q1/1D).
01/09/2025 Coronary revascularization and sex differences in cardiovascular mortality after myocardial infarction in 12 high and middle-income European countries
Cenko, E, Yoon, J, Bergami, M, Gale, CP, Vasiljevic, Z, Vavlukis, M, Kedev, S, Milicic, D, Dorobantu, M, Badimon, L, Manfrini, O, Bugiardini, R. Coronary revascularization and sex differences in cardiovascular mortality after myocardial infarction in 12 high and middle-income European countries. European Heart Journal-Quality of Care and Clinical Outcomes. 2025; 11(6)DOI:10.1093/ehjqcco/qcae035. PMID:38714331. IF:4.600(Q1/2D).
01/09/2025 A miRNA signature linked to high lipoprotein (a) and coronary calcification in familial hypercholesterolaemia
Escate, R, Muñoz-Torrero, JS, Mauri, M, Mata, P, Badimon, L, Padro, T. A miRNA signature linked to high lipoprotein (a) and coronary calcification in familial hypercholesterolaemia. Computational and Structural Biotechnology Journal. 2025; 27DOI:10.1016/j.csbj.2025.09.026. PMID:41035502. IF:4.100(Q2/4D).
01/09/2025 Polygenic prediction of body mass index and obesity through the life course and across ancestries
Smit, RAJ, Wade, KH, Hui, Q, Arias, JD, Yin, XY, Christiansen, MR, Yengo, L, Preuss, MH, Nakabuye, M, Rocheleau, G, Graham, SE, Buchanan, VL, Chittoor, G, Graff, M, Guindo-Martínez, M, Lu, YC, Marouli, E, Sakaue, S, Spracklen, CN, Vedantam, S, Wilson, EP, Chen, SH, Ferreira, T, Ji, YJ, Karaderi, T, Lüll, K, Machado, M, Malden, DE, Medina-Gomez, C, Moore, A, Rüeger, S, Akiyama, M, Allison, MA, Alvarez, M, Andersen, MK, Appadurai, V, Arbeeva, L, Bartell, E, Bhaskar, S, Bielak, LF, Bis, JC, Bollepalli, S, Bork-Jensen, J, Bradfield, JP, Bradford, Y, Brandl, C, Braund, PS, Brody, JA, Broeckel, U, Burgdorf, KS, Cade, BE, Cai, QY, Camarda, S, Campbell, A, Cañadas-Garre, M, Chai, JF, Chesi, A, Choi, SH, Christofidou, P, Couture, C, Cuellar-Partida, G, Danning, R, Degenhardt, F, Delgado, GE, Delitala, A, Demirkan, A, Deng, X, Dietl, A, Dimitriou, M, Dimitrov, L, Dorajoo, R, Eichelmann, F, Eliasen, AU, Engmann, JE, Erdos, MR, Fairhurst-Hunter, Z, Farmaki, AE, Faul, JD, Fernandez-Lopez, JC, Forer, L, Frank, M, Freitag-Wolf, S, Fritsche, LG, Fuchsberger, C, Galesloot, TE, Gao, Y, Geller, F, Giannakopoulou, O, Giulianini, F, Gjesing, AP, Goel, A, Gordon, SD, Gorski, M, Grove, J, Guo, XQ, Gustafsson, S, Haessler, J, Hansen, TF, Havulinna, AS, Haworth, SJ, Heard-Costa, N, Hemerich, D, Highland, HM, Hindy, G, Ho, YL, Hofer, E, Holliday, E, Horn, K, Hornsby, WE, Hottenga, JJ, Huang, HY, Huang, J, Huerta-Chagoya, A, Huo, SF, Hwang, MY, Hwu, CM, Iha, H, Ikeda, DD, Isono, M, Jackson, AU, Jansen, IE, Jiang, YX, Johansson, I, Jonsson, A, Jorgensen, T, Kalafati, IP, Kanai, M, Kanoni, S, Kårhus, LL, Kasturiratne, A, Katsuya, T, Kawaguchi, T, Kember, RL, Kentistou, KA, Kim, D, Kim, HN, Kim, YJ, Kleber, ME, Knol, MJ, Kurbasic, A, Lauzon, M, Le, P, Lea, R, Lee, JY, Lee, WJ, Leonard, HL, Li, HT, Li, SCA, Li, XH, Li, XY, Liang, JJ, Lin, HH, Lin, K, Liu, J, Liu, XP, Lo, KS, Long, JR, Lores-Motta, L, Luan, JA, Lyssenko, V, Lyytikäinen, LP, Mahajan, A, Malik, MZ, Mamakou, V, Mangino, M, Manichaikul, A, Marten, J, Mattheisen, M, McDaid, AF, Mei, QS, Meiselbach, H, Melendez, TL, Milaneschi, Y, Miller, JE, Millwood, IY, Mishra, PP, Mitchell, RE, Mollehave, LT, Mononen, N, Mucha, S, Munz, M, Mykkaenen, J, Nakatochi, M, Nardone, GG, Nelson, CP, Nethander, M, Nho, CW, Nielsen, AA, Nolte, IM, Nongmaithem, SS, Noordam, R, Ntalla, I, Nutile, T, Pandit, A, Pauper, M, Petersen, ERB, Petersen, LV, Piluso, F, Polasek, O, Poveda, A, Pyarajan, S, Raffield, LM, Rakugi, H, Ramirez, J, Rasheed, A, Raven, D, Rayner, NW, Riveros, C, Rohde, R, Ruggiero, D, Ruotsalainen, SE, Ryan, KA, Sabater-Lleal, M, Santin, A, Saxena, R, Scholz, M, Shen, BT, Shi, JCZ, Shin, JH, Sidore, C, Sidorenko, J, Sim, X, Slieker, RC, Smith, AV, Smith, JA, Smyth, LJ, Southam, L, Steinthorsdottir, V, Sun, L, Takeuchi, F, Taylor, KD, Tayo, BO, Tcheandjieu, C, Terzikhan, N, Tesolin, P, Teumer, A, Theusch, E, Thompson, DJ, Thorleifsson, G, Timmers, PRHJ, Trompet, S, Turman, C, Vaccargiu, S, van der Laan, SW, van der Most, PJ, van Klinken, JB, van Setten, J, Verma, SS, Verweij, N, Veturi, Y, Wang, CA, Wang, CL, Wang, JS, Wang, LH, Wang, YX, Wang, Z, Warren, HR, Wei, WB, Wen, WQ, Wheeler, WA, Wickremasinghe, AR, Wielscher, M, Winsvold, BS, Wong, A, Wuttke, M, Xia, R, Yamamoto, K, Yang, JY, Yao, J, Young, H, Yousri, NA, Yu, L, Zeng, LY, Zhang, WH, Zhang, XY, Zhao, JH, Zhao, W, Zhou, W, Zimmermann, ME, Zoledziewska, M, 't Hart, LM, Adair, LS, Adams, HHH, Aguilar-Salinas, CA, Al-Mulla, F, Arnett, DK, Asselbergs, FW, Asvold, BO, Attia, J, Banas, B, Bandinelli, S, Beilin, LJ, Bennett, DA, Bergler, T, Bharadwaj, D, Biino, G, Boerwinkle, E, Boeger, CA, Borja, JB, Bouchard, C, Bowden, DW, Brandslund, I, Ben Brumpton,, Buring, JE, Caulfield, MJ, Chambers, JC, Chandak, GR, Chanock, SJ, Chaturvedi, N, Chen, YDI, Chen, ZM, Cheng, CY, Cho, YS, Christensen, K, Christophersen, IE, Ciullo, M, Cole, JW, Collins, FS, Concas, MP, Cooper, RS, Cruz, M, Cucca, F, Cutler, MJ, Damrauer, SM, Dantoft, TM, de Borst, GJ, de Geus, EJC, de Groot, LCPGM, De Jager, PL, de Kleijn, DPV, de Silva, HJ, Dedoussis, GV, den Hollander, AI, Du, SF, Easton, DF, Eckardt, KU, Elders, PJM, Eliassen, AH, Ellinor, PT, Elmståhl, S, Erdmann, J, Evans, MK, Fatkin, D, Feenstra, B, Feitosa, MF, Ferrucci, L, Florez, JC, Ford, I, Fornage, M, Franke, A, Franks, PW, Freedman, BI, Gieger, C, Girotto, G, Golightly, YM, Gonzalez-Villalpando, C, Gordon-Larsen, P, Grallert, H, Grant, SFA, Grarup, N, Griffiths, L, Gudnason, V, Haiman, C, Hakonarson, H, Hansen, T, Hartman, CA, Hattersley, AT, Hayward, C, Heid, IM, Heng, CK, Hengstenberg, C, Herzig, KH, Hewitt, AW, Hishigaki, H, Hougaard, DM, Hoyng, CB, Huang, PL, Huang, W, Huang, WY, Huffman, JE, Hunt, SC, Hutri, N, Hveem, K, Hyppoenen, E, Iacono, WG, Ichihara, S, Ikram, MA, Isasi, CR, Jarvelin, MR, Jin, ZB, Joeckel, KH, Jonas, JB, Joshi, PK, Jousilahti, P, Jukema, JW, Kaehoenen, M, Kamatani, Y, Kang, KD, Kaprio, J, Kardia, SLR, Karpe, F, Kato, N, Kavousi, M, Kee, F, Kessler, T, Khera, AV, Khor, CC, Kiemeney, LALM, Kim, BJ, Kim, EK, Kim, HL, Kirchhof, P, Kivimaki, M, Koh, WP, Koistinen, HA, Kokkinos, A, Kooner, JS, Kooperberg, C, Kovacs, P, Kraaijeveld, A, Kraft, P, Krauss, RM, Kumari, M, Kutalik, Z, Laakso, M, Lange, LA, Langenberg, C, Launer, LJ, Lee, H, Lee, NR, Lehtimaeki, T, Lemaitre, RN, Li, HX, Li, LM, Lieb, W, Lin, X, Lind, L, Linneberg, A, Liu, CT, Liu, JJ, Loeffler, M, London, B, Lu, F, Lubitz, SA, Mackey, DA, Magnusson, PKE, Manson, JE, Marcus, GM, Vidal, PM, Martin, NG, März, W, Matsuda, F, McCarthy, MI, McGarrah, RW, McGue, M, McKnight, AJ, Medland, SE, Mellström, D, Metspalu, A, Mitchell, BD, Mitchell, P, Mook-Kanamori, DO, Mori, TA, Morris, AD, Mucci, LA, Munroe, PB, Nalls, MA, Nazarian, S, Nelson, AE, Neville, MJ, Newton-Cheh, C, Nielsen, CS, Niinikoski, H, Nikus, K, Noethen, MM, Ogunniyi, A, Ohlsson, C, Oldehinkel, AJ, Orozco, L, Pahkala, K, Pajukanta, P, Palmer, CNA, Parra, EJ, Pattaro, C, Pedersen, O, Pennell, CE, Penninx, BWJH, Perusse, L, Peters, A, Peyser, PA, Porteous, DJ, Posthuma, D, Power, C, Pramstaller, PP, Province, MA, Psaty, BM, Qi, QB, Qu, J, Rader, DJ, Raitakari, OT, Rallidis, LS, Rao, DC, Redline, S, Reilly, DF, Reiner, AP, Rhee, SY, Ridker, PM, Rienstra, M, Ripatti, S, Ritchie, MD, Rivadeneira, F, Roden, DM, Rosendaal, FR, Rotter, JI, Rudan, I, Rutters, F, Ryu, S, Sabanayagam, C, Salako, B, Saleheen, D, Salomaa, V, Samani, NJ, Sanghera, DK, Sattar, N, Schmidt, B, Schmidt, H, Schmidt, R, Schulze, MB, Schunkert, H, Scott, LJ, Scott, RJ, Sever, P, Sheu, WHH, Shoemaker, MB, Shu, XO, Simonsick, EM, Sims, M, Singleton, AB, Sinner, MF, Smith, JG, Snieder, H, Spector, TD, Spedicati, B, Stampfer, MJ, Stark, KJ, Strachan, DP, Tabara, Y, Tai, ES, Tang, H, Tardif, JC, Thanaraj, TA, Toenjes, A, Tuomi, T, Tuomilehto, J, Tusie-Luna, MT, van Dam, RM, van der Harst, P, van der Velde, N, van Duijn, CM, van Schoor, NM, Vitart, V, Vohl, MC, Völker, U, Vollenweider, P, Völzke, H, Vrieze, S, Wacher-Rodarte, NH, Walker, M, Wander, GS, Wareham, NJ, Watanabe, RM, Watkins, H, Weir, DR, Werge, TM, Widen, E, Willemsen, G, Willett, WC, Wilson, JF, Wilson, PWF, Wong, TY, Woo, JT, Wright, AF, Xu, HC, Yajnik, CS, Yang, J, Yokota, M, Yuan, JM, Zeggini, E, Zemel, BS, Zheng, W, Zhu, XF, Zillikens, MC, Zonderman, AB, Zwart, JA, Abecasis, GR, Assimes, TL, Auton, A, Boehnke, M, Chasman, DI, Esko, T, Stefansson, K, Lettre, G, Lindgren, CM, Ng, MCY, O'Donnell, CJ, Thorsteinsdottir, U, Visscher, PM, Walters, RG, Winkler, TW, Wood, AR, Deloukas, P, Frayling, TM, Justice, AE, Kilpelainen, TO, Locke, AE, Mohlke, KL, North, KE, Okada, Y, Willer, CJ, Young, KL, Fatumo, S, McCaffery, JM, Timpson, NJ, Hirschhorn, JN, Sun, YV, Berndt, SI, Loos, RJF. Polygenic prediction of body mass index and obesity through the life course and across ancestries. NATURE MEDICINE. 2025; 31(9)DOI:10.1038/s41591-025-03827-z. PMID:40691366. IF:50.000(Q1/1D).
01/09/2025 Lipids and lipoproteins in the interstitial tissue fluid regulate the formation of dysfunctional tissue-resident macrophages: Implications for atherogenic, tumorigenic, and obesogenic processes
Lee-Rueckert, M, Jauhiainen, M, Kovanen, PT, Escolà-Gil, JC. Lipids and lipoproteins in the interstitial tissue fluid regulate the formation of dysfunctional tissue-resident macrophages: Implications for atherogenic, tumorigenic, and obesogenic processes. SEMINARS IN CANCER BIOLOGY. 2025; 114DOI:10.1016/j.semcancer.2025.06.008. PMID:40545184. IF:15.700(Q1/1D).
01/09/2025 A study on the utilization of canagliflozin in type 1 diabetes mellitus using real-world data from four European countries
Voss, EA, Yuan, Z, Ali, SR, Bosan, R, Eworuke, E, Brewster, J, Vlacho, B, Fernández-Camins, B, Fernández-Bertolín, S, Fonseca, S, Jeffcoat, C, Wang, L. A study on the utilization of canagliflozin in type 1 diabetes mellitus using real-world data from four European countries. DIABETES OBESITY & METABOLISM. 2025; 27(9)DOI:10.1111/dom.16574. PMID:40605139. IF:5.700(Q1/2D).
01/09/2025 Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline
Wyckoff, JA, Lapolla, A, Asias-Dinh, BD, Barbour, LA, Brown, FM, Catalano, PM, Corcoy, R, Di Renzo, GC, Drobycki, N, Kautzky-Willer, A, Murad, MH, Stephenson-Gray, M, Tabák, AG, Weatherup, E, Zera, C, Singh-Ospina, N. Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2025; 110(9)DOI:10.1210/clinem/dgaf288. PMID:40652453. IF:5.100(Q1/2D).
01/09/2025 Integration of Artificial Intelligence-Enhanced Capsule Endoscopy in Clinical Practice: A Review of Market-Available Tools for Clinical Practice
Giordano, A, Romero-Mascarell, C, González-Suárez, B, Guarner-Argente, C. Integration of Artificial Intelligence-Enhanced Capsule Endoscopy in Clinical Practice: A Review of Market-Available Tools for Clinical Practice. DIGESTIVE DISEASES AND SCIENCES. 2025; 70(9)DOI:10.1007/s10620-025-09099-4. PMID:40490597. IF:2.500(Q2/5D).
01/09/2025 ANCA associated pulmonary fibrosis: vasculitis or not vasculitis
Codes-Méndez, H, Castillo, D, Moya-Alvarado, P, Giménez-Palleiro, A, Castellvi, I. ANCA associated pulmonary fibrosis: vasculitis or not vasculitis. CURRENT OPINION IN PULMONARY MEDICINE. 2025; 31(5)DOI:10.1097/MCP.0000000000001187. PMID:40548517. IF:2.800(Q2/5D).
01/09/2025 Trends in time to withdrawal and full approval of accelerated approval cancer drug indications (1992-2024)
Jenei, K, Hahn, G, Kesselheim, AS, Tibau, A. Trends in time to withdrawal and full approval of accelerated approval cancer drug indications (1992-2024). Journal Of Cancer Policy. 2025; 45DOI:10.1016/j.jcpo.2025.100597. PMID:40472969. IF:(Q/D).
01/09/2025 Lenvatinib plus pembrolizumab in pretreated metastatic B3 thymoma and thymic carcinoma (PECATI): a single-arm, phase 2 trial
Remon, J, Bironzo, P, Girard, N, Bigay-Game, L, Juan-Vidal, O, de Castro, J, Reguart, N, Greillier, L, Cousin, S, Dansin, E, Majem, M, Bernabe, R, Martinez, JM, Diaz, M, Meya, A, Alcalá-López, D, Garcia-Sanz, A, Righi, L, Novello, S, Besse, B. Lenvatinib plus pembrolizumab in pretreated metastatic B3 thymoma and thymic carcinoma (PECATI): a single-arm, phase 2 trial. LANCET ONCOLOGY. 2025; 26(9)DOI:10.1016/S1470-2045(25)00300-6. PMID:40907517. IF:35.900(Q1/1D).
01/09/2025 Enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer: results of the EORTC 1333/PEACE-3 trial
Tombal, B, Choudhury, A, Saad, F, Gallardo, E, Soares, A, Loriot, Y, Mcdermott, R, Rodriguez-Vida, A, Velho, PI, Nolè, F, Cruz, F, Roumeguere, T, Daugaard, G, Yamamura, R, Bompas, E, Maroto, P, Veiga, FG, Skoneczna, I, Trindade, KMD, Carcano, FM, Lecouvet, F, Coens, C, Poncet, C, Fournier, B, Gillessen, S, Crua, F. Enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer: results of the EORTC 1333/PEACE-3 trial. ANNALS OF ONCOLOGY. 2025; 36(9)DOI:10.1016/j.annonc.2025.05.011. PMID:40450503. IF:65.400(Q1/1D).
01/09/2025 Telomere attrition becomes an instrument for clonal selection in aging hematopoiesis and leukemogenesis
Mcloughlin, MA, Kovilakam, SC, Dunn, WG, Gu, MX, Tobin, J, Pershad, Y, Williams, N, Leongamornlert, D, Dawson, K, Bond, L, Marando, L, Wen, S, Wilson, R, Valenzano, G, Symeonidou, V, Rak, J, Damaskou, A, Gozdecka, M, Liu, XX, Barcena, C, Nomdedeu, J, Costeas, P, Dimitriou, ID, Fiorillo, E, Orrù, V, de Almeida, JG, Mckerrell, T, Cullen, M, Mohorianu, I, Foukaneli, T, Warren, AJ, Wong, C, Follows, G, Godfrey, AL, Gudgin, E, Cucca, F, Mckinney, E, Baxter, EJ, Gerstung, M, Mitchell, J, Wiseman, D, Bick, AG, Fabre, M, Quiros, PM, Nangalia, J, Kar, S, Vassiliou, GS. Telomere attrition becomes an instrument for clonal selection in aging hematopoiesis and leukemogenesis. NATURE GENETICS. 2025; 57(9)DOI:10.1038/s41588-025-02296-x. PMID:40877435. IF:29.000(Q1/1D).
01/09/2025 Clinical characteristic and outcome of HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: A study of Infectious Disease Working Party of EBMT
Perruccio, K, Ward, KN, Tridello, G, Knelange, N, Zeiser, R, Franke, GN, Sirvent, A, Einsele, H, Vicent, MG, Navarro, JMF, Contentin, N, Collin, M, Martino, R, Gambella, M, Sengeloev, H, Passweg, J, Snowden, J, Nagler, A, Kulagin, A, Gabriel, M, Kröger, N, Cascon, MJP, Yeshurun, M, Güngör, T, Robin, C, Clark, A, Duarte, ML, Amor, AA, Itala-Remes, M, Mikulska, M, Styczynski, J, de la Camara, R, Ljungman, P, Averbuch, D, Cesaro, S. Clinical characteristic and outcome of HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: A study of Infectious Disease Working Party of EBMT. BONE MARROW TRANSPLANTATION. 2025; 60(9)DOI:10.1038/s41409-025-02638-7. PMID:40461849. IF:5.200(Q1/1D).
01/09/2025 Cytomegalovirus DNA Doubling Time for Early Identification of Clinically Significant Infection Episodes in Allogeneic Hematopoietic Stem Cell Transplant Recipients Undergoing Primary Letermovir Prophylaxis: A Multicenter Study
Giménez, E, Cadenas, IG, Piñana, JL, Albert, E, Vázquez, L, Avendaño, A, Cabrero, M, Esquirol, A, Martino, R, López-Jiménez, J, Cuesta, MA, Humala, K, Villar, S, Rovira, M, Heras, I, Zudaire, T, Arroyo, I, Zabalza, A, Aguado, B, Solano, C, Navarro, D. Cytomegalovirus DNA Doubling Time for Early Identification of Clinically Significant Infection Episodes in Allogeneic Hematopoietic Stem Cell Transplant Recipients Undergoing Primary Letermovir Prophylaxis: A Multicenter Study. Transplant Infectious Disease. 2025; 27(5)DOI:10.1111/tid.70080. PMID:40674366. IF:2.600(Q1/1D).
01/09/2025 Blood-based biomarkers for Alzheimer's disease: Positioning document and usage recommendations from the Behavioral Neurology and Dementia Study Group of the Spanish Society of Neurology
Suárez-Calvet, M, Abdelnour, C, Alcolea, D, Mendióroz-Iriarte, M, Balasa, M, Morenas-Rodríguez, E, Puig-Pijoan, A, Sánchez-Juan, P, Villarejo-Galende, A, Sánchez-Valle, R. Blood-based biomarkers for Alzheimer's disease: Positioning document and usage recommendations from the Behavioral Neurology and Dementia Study Group of the Spanish Society of Neurology. NEUROLOGIA. 2025; 40(7)DOI:10.1016/j.nrleng.2025.07.004. PMID:40685136. IF:3.100(Q2/4D).
01/09/2025 Determinantes de tuberculosis en la población que ingresa en prisiones de Cataluña
Marco, A., Solé, N., Prieto-García, R, Abdo, I.J., Millet J.P., Turu, E.. Determinantes de tuberculosis en la población que ingresa en prisiones de Cataluña. Revista Española de Sanidad Penitenciaria. 2025; 27(3)DOI:. PMID:. IF:(Q/D).
01/09/2025 Management of Kidney Disease in Heart Transplant Patients: A National Delphi Survey-based Consensus Expert Paper
García-Cosío Carmena, MD, Farrero, M, Blasco Peiró, MT, Crespo, M, Delgado Jiménez, J, Díaz Molina, B, Fernández Rivera, C, Garrido Bravo, IP, López Jiménez, V, Melilli, E, Mirabet Pérez, S, Pérez Tamajón, ML, Rangel Sousa, D, Rodrigo, E, Cruzado, JM, Hernández Marrero, D. Management of Kidney Disease in Heart Transplant Patients: A National Delphi Survey-based Consensus Expert Paper. TRANSPLANTATION. 2025; 109(9)DOI:10.1097/TP.0000000000005302. PMID:39928546. IF:5.000(Q1/1D).
01/09/2025 Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Audisio, A, Gallio, C, Velenik, V, Meillat, H, Ruiz-Garcia, E, Riesco, MC, Alecha, JS, Rasschaert, G, Carvalho, C, Randrian, V, Kirac, I, Hernando, J, Artac, M, O'Connor, JM, Waldhorn, I, Braam, PM, Shamseddine, A, Moretto, R, de la Pinta, C, De Felice, F, Dulskas, A, Lopez-Bravo, DP, Vanden Bulcke, A, Bock, F, Deleporte, A, van den Eynde, M, Geboes, KP, Loi, M, Messina, M, Houlze-Laroye, C, Puccini, A, Pastorino, A, Papamichael, D, Fiore, M, Sur, D, Eid, M, Antoun, C, Salati, M, Garajova, I, Jakubauskas, M, Tomasek, J, Pinto, CMS, Schwingel, J, Morano, F, Adams, RA, Dermine, A, Chau, A, Javed, MA, Ghidini, M, Fiorica, F, Montenegro, P, Petrillo, A, Spolverato, G, Margalef, NM, Diaz, M, Baratelli, C, Puleo, F, Karampeazis, A, Sert, F, Gilliaux, Q, De Stefano, A, Liberale, G, Moretti, L, Martinive, P, Thomas, VD, Staggs, V, Saad, ED, Van Laethem, JL, Sclafani, F. Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer. JAMA Oncology. 2025; 11(9)DOI:10.1001/jamaoncol.2025.2026. PMID:40638097. IF:20.100(Q1/1D).
01/09/2025 Recommended Phase 2 Dose (RP2D) Determination of Bleximenib in Combination With Venetoclax plus Azacitidine (VEN plus AZA): Phase Ib Study in Newly Diagnosed (ND) and Relapsed/ Refractory (R/R) Acute Myeloid Leukemia (AML) With KMT2A or NPM1 Alterations
Wei, AH, Reyner, JE, Garciaz, S, Aldoss, I, Piérola, A, Allred, A, Dominguez, JMA, Barreyro, L, Bories, P, Daskalakis, N, Porta, MGD, Döhner, H, D'Souza, A, Dugan, J, Fathi, A, Fedele, P, Ferrante, L, Kobos, R, Gaj, S, Diaz, AG, Paniagua, SG, Guttke, C, Gyan, E, Hiebert, B, Jabbour, E, Trancucci, D, Bamidele, T, Jentzsch, M, Kantarjian, H, Konopleva, M, Krönke, J, Hütter-Krönke, ML, Loefgren, C, Lomas, O, Mancini, V, Mantzaris, I, Morillo, D, O'Nions, J, Packman, K, Papayannidis, C, Récher, C, Roellig, C, Salamero, O, Nagarajahastri, P, Sauer, T, Searle, E, Tovar, N, Vallet, N, Vaughan, L, Vega, G, Vyas, P, Platzbecker, U. Recommended Phase 2 Dose (RP2D) Determination of Bleximenib in Combination With Venetoclax plus Azacitidine (VEN plus AZA): Phase Ib Study in Newly Diagnosed (ND) and Relapsed/ Refractory (R/R) Acute Myeloid Leukemia (AML) With KMT2A or NPM1 Alterations. Clinical Lymphoma Myeloma & Leukemia. 2025; 25DOI:. PMID:. IF:2.700(Q2/4D).
01/09/2025 Characteristics of Long-Term Survivors in Multiple Myeloma: Exploring Factors for Cure After Extended Follow-Up
Fernandez, RA, Arroyo, A, Cedena, MT, Rosiñol, L, De la Rubia, J, Miqueleiz, S, González-Calle, V, de Arriba, F, Casado-Montero, F, Hernandez, MT, Mas, M, Fernandez-Abellan, P, Rodriguez-Otero, P, Calle, C, Abella, E, Ribas, P, Alegre, A, Bergua, JM, Ocio, E, De la Cruz, J, Mateos, MV, San-Miguel, J, Bladé, J, Lahuerta, JJ, Martinez-Lopez, J. Characteristics of Long-Term Survivors in Multiple Myeloma: Exploring Factors for Cure After Extended Follow-Up. Clinical Lymphoma Myeloma & Leukemia. 2025; 25DOI:. PMID:. IF:2.700(Q2/4D).
01/09/2025 Denervated human muscle fibers promote reinnervation via neurotrophic factor release in SMA and ALS
Gokul-Nath, R, Collins, C, Valverde, L, Lleixa, C, Verdu-Diaz, J, Di Lorenzo, A, Llarch, P, Querol, L, Marini-Bettolo, C, Rojas-Garcia, R, Diaz-Manera, J. Denervated human muscle fibers promote reinnervation via neurotrophic factor release in SMA and ALS. NEUROMUSCULAR DISORDERS. 2025; 53DOI:10.1016/j.nmd.2025.105462. PMID:. IF:2.800(Q2/5D).
01/09/2025 Study of brain perfusion in adults with Down syndrome along the Alzheimer's disease continuum
Franquesa-Mullerat, M, Morcillo-Nieto, AO, Arriola-Infante, JE, Zsadanyi, SE, Vaqué-Alcázar, L, Rozalem-Aranha, M, Arranz, J, Rodríguez-Baz, I, Maure-Blesa, L, Videla, L, Barroeta, I, Soriano, LD, Benejam, B, Fernández, S, Hernandez, AS, Giménez, S, Alcolea, D, Belbin, O, Lleó, A, Carmona-Iragui, M, Fortea, J, Bejanin, A. Study of brain perfusion in adults with Down syndrome along the Alzheimer's disease continuum. ALZHEIMERS & DEMENTIA. 2025; 21(9)DOI:10.1002/alz.70581. PMID:40968330. IF:11.100(Q1/1D).
01/09/2025 Gender and socioeconomic inequalities in adolescent mental well-being in Barcelona: a repeated cross-sectional study
Olivella-Cirici, M, Vilagut, G, Sánchez-Ledesma, E, Serral, G, Cortés-Albaladejo, M, Cejas, PM, Pasarín, M, Alonso, J, Pérez, G. Gender and socioeconomic inequalities in adolescent mental well-being in Barcelona: a repeated cross-sectional study. Journal Of Public Health-Heidelberg. 2025; DOI:10.1007/s10389-025-02573-3. PMID:. IF:(Q/D).
01/09/2025 Bimekizumab efficacy in patients with plaque psoriasis: A post hoc stratification by weight over 4 years in BE BRIGHT
Gkini, MA, López-Ferrer, A, Magnolo, N, Soung, J, Trafford, A, Pousa, ID, Kavanagh, S, Gooderham, M. Bimekizumab efficacy in patients with plaque psoriasis: A post hoc stratification by weight over 4 years in BE BRIGHT. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2025; 93(3)DOI:. PMID:. IF:11.800(Q1/1D).